A comprehensive review of molecular optimization in artificial intelligence‐based drug discovery

Pub Date : 2024-02-12 DOI:10.1002/qub2.30
Yuhang Xia, Yongkang Wang, Zhiwei Wang, Wen Zhang
{"title":"A comprehensive review of molecular optimization in artificial intelligence‐based drug discovery","authors":"Yuhang Xia, Yongkang Wang, Zhiwei Wang, Wen Zhang","doi":"10.1002/qub2.30","DOIUrl":null,"url":null,"abstract":"Drug discovery is aimed to design novel molecules with specific chemical properties for the treatment of targeting diseases. Generally, molecular optimization is one important step in drug discovery, which optimizes the physical and chemical properties of a molecule. Currently, artificial intelligence techniques have shown excellent success in drug discovery, which has emerged as a new strategy to address the challenges of drug design including molecular optimization, and drastically reduce the costs and time for drug discovery. We review the latest advances of molecular optimization in artificial intelligence‐based drug discovery, including data resources, molecular properties, optimization methodologies, and assessment criteria for molecular optimization. Specifically, we classify the optimization methodologies into molecular mapping‐based, molecular distribution matching‐based, and guided search‐based methods, respectively, and discuss the principles of these methods as well as their pros and cons. Moreover, we highlight the current challenges in molecular optimization and offer a variety of perspectives, including interpretability, multidimensional optimization, and model generalization, on potential new lines of research to pursue in future. This study provides a comprehensive review of molecular optimization in artificial intelligence‐based drug discovery, which points out the challenges as well as the new prospects. This review will guide researchers who are interested in artificial intelligence molecular optimization.","PeriodicalId":0,"journal":{"name":"","volume":"72 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/qub2.30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Drug discovery is aimed to design novel molecules with specific chemical properties for the treatment of targeting diseases. Generally, molecular optimization is one important step in drug discovery, which optimizes the physical and chemical properties of a molecule. Currently, artificial intelligence techniques have shown excellent success in drug discovery, which has emerged as a new strategy to address the challenges of drug design including molecular optimization, and drastically reduce the costs and time for drug discovery. We review the latest advances of molecular optimization in artificial intelligence‐based drug discovery, including data resources, molecular properties, optimization methodologies, and assessment criteria for molecular optimization. Specifically, we classify the optimization methodologies into molecular mapping‐based, molecular distribution matching‐based, and guided search‐based methods, respectively, and discuss the principles of these methods as well as their pros and cons. Moreover, we highlight the current challenges in molecular optimization and offer a variety of perspectives, including interpretability, multidimensional optimization, and model generalization, on potential new lines of research to pursue in future. This study provides a comprehensive review of molecular optimization in artificial intelligence‐based drug discovery, which points out the challenges as well as the new prospects. This review will guide researchers who are interested in artificial intelligence molecular optimization.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
基于人工智能的药物发现中的分子优化综合评述
药物发现的目的是设计出具有特定化学特性的新型分子,用于治疗目标疾病。一般来说,分子优化是药物发现的一个重要步骤,它可以优化分子的物理和化学性质。目前,人工智能技术在药物发现领域取得了巨大成功,已成为应对包括分子优化在内的药物设计挑战的新策略,并大大降低了药物发现的成本和时间。我们回顾了基于人工智能的药物发现中分子优化的最新进展,包括数据资源、分子特性、优化方法和分子优化的评估标准。具体而言,我们将优化方法分别分为基于分子图谱的方法、基于分子分布匹配的方法和基于引导搜索的方法,并讨论了这些方法的原理及其利弊。此外,我们还强调了当前分子优化所面临的挑战,并从可解释性、多维优化和模型泛化等多个角度探讨了未来可能的新研究方向。本研究对基于人工智能的药物发现中的分子优化进行了全面综述,指出了面临的挑战和新的前景。本综述将为对人工智能分子优化感兴趣的研究人员提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1